Lineage Cell Therapeutics, Inc.
USD1.10
-0.06 (-5.17%)
CEO
Brian Culley
IPO Date
1992-03-05
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$1.16
Prev. Close
$1.16
Day Low
$1.09
Day High
$1.17
52W Low
$0.93
52W High
$2.09
Market Cap
$0.27B
Volume
1.67M
| 125,000 |
| $1.30 |
| 2 Jul 2026 | Mulroy Michael H. | director | A-Award | Acquired | 125,000 | $1.30 |
| 2 Jul 2026 | ANDREWS DEBORAH J | director | A-Award | Acquired | 125,000 | $1.30 |
| 2 Jul 2026 | Russell Angus C. | director | A-Award | Acquired | 125,000 | $1.30 |
| 2 Jul 2026 | Amin Dipti | director | A-Award | Acquired | 125,000 | $1.30 |
| 12 Mar 2026 | Culley Brian M | director, officer: President and CEO | P-Purchase | Acquired | 15,000 | $1.63 |
| 6 Mar 2026 | Culley Brian M | director, officer: President and CEO | A-Award | Acquired | 3,250,000 | $1.84 |
| 6 Mar 2026 | Howe Jill Ann | Chief Financial Officer | A-Award | Acquired | 1,050,000 | $1.84 |
| 6 Mar 2026 | Samuel George A. III | General Counsel and Secretary | A-Award | Acquired | 900,000 | $1.84 |